SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-11-023619
Filing Date
2011-04-20
Accepted
2011-04-20 14:10:31
Documents
2
Period of Report
2011-04-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2162
2 POA DOCUMENT poa.txt EX-24.3_374407 3501
  Complete submission text file 0001209191-11-023619.txt   7105
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451
Business Address
Hart Danny J Jr. (Reporting) CIK: 0001518546 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19756 | Film No.: 11770306